Methods for treating antibiotic-resistant infections
AssigneeThe United States of America as represented by the Secretary of the Army
InventorsWilliam Y. Ellis, Calvin M. Kunin
Life of this patent
Estimating the term…
Abstract
This invention relates to the treatment of antibiotic-resistant infections, including particularly infections caused by bacteria, Mycobacteria and fungi. A preferred group of compositions of the invention contain as active agents compounds containing pyridyl, quinolyl or benzoquinolyl ring systems substituted on the nitrogen-containing ring at the carbon opposite the nitrogen by a carbon bound to an oxygen which is also bound to a nitrogen through a saturated carbon or carbon chain, or, in the case of the pyridyl ring system, the substituent at the 4 position of the pyridyl ring may be an alkyl which may be substituted with halo, hydroxy, alkoxy, amino or alkylamino.
Claims11
A method of treating a patient suffering from infection caused by bacteria, mycobacteria or fungi by administration to said patient of a composition containing as an active agent bacteria, mycobacterium or yeast growth-inhibiting effective amount of a compound of the formula:
- wherein B is a carbon (C′) bound to an oxygen, (═O, OH, Oalk, OCOalk, OCOaryl, OCOphenyl alkyl, or an oxygen in a cyclic moiety wherein aryl is phenyl or naphthyl and alkyl has 1-4 carbons and may be substituted hydroxy, or with 1-2 halo atoms, said moeities being defined as A) and wherein said carbon C′ is also bound to a saturated carbon which is bond directly to a nitrogen-containing saturated chain or nitrogen-containing saturated ring system (for example, piperidinyl or quinuclidinyl ring systems), wherein any saturated ring system may be substituted with alkyl, alkenyl, halo, alkoxy or haloalkyl moieties of 1-5 carbons or with phenyl, phenoxy, phenylalkyl, phenylalkoxy, carboxy or carbonyl groups, wherein the carboxy or carbonyl groups, including keto or ester moieties with alkyl groups of 1-4 carbons, alkenyl groups of 2-5 carbons or phenylalkyl wherein the alkyl is of 1-3 carbons or wherein Z is R1 and/or R2 wherein at least one of R1 and R2 is an electron-rich substituent and n may be 1-4 and wherein R1 and/or R2 may be alkyl, alkoxy, aryl, aryloxy, aryloxyalkyl, amino, amino-alkyl, alkyl-aminoalkyl, arylamino, alkenyl, arylalkenyl, arylalkylaminoalkyl, carboxyalkyl, hydroxy, halo, alkenyl, alkenyloxy, herein any alkyl has 1-8 carbons, alkenyl has 2-8 carbons, wherein halo is chloro, fluoro or bromo and aryl is a ring system of 1-3 rings which may be substituted by halo, alkyl, alkoxy, alkenyl, alkenyloxy, wherein any alkyl may be subsituted with halo, amino or alkoxy.
A method of the invention wherein the composition is administered to the mucosa.
A method of the invention wherein the composition is administered parenterally.
Dependencies are inferred from the claim text.